There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Introduction: Over 4.9 million cases of Coronavirus disease 2019 (COVID-19) have been
confirmed since the worldwide pandemic began. Since the emergence of COVID-19, a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can give rise to
different clinical manifestations that are directly related to viral tissue damage or indirectly …

Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in
overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …

The clinical and immunological spectrum of acute and post-active COVID-19 syndrome
overlaps with criteria used to characterize autoimmune diseases such as rheumatoid …

Introduction Covid-19 infection poses a serious challenge for immune-compromised patients
with inflammatory autoimmune systemic diseases. We investigated the clinical …

Currently, few evidences have shown the possible involvement of autoimmunity in patients
affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether …

We present a review of the association between COVID-19 and autoimmune diseases,
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …